First Wilshire Reduces Camtek Stake by 81,598 Shares, Valuation Drops by $2.67 Million
- Reduction Action: First Wilshire Securities Management sold 81,598 shares of Camtek in Q3, resulting in a $2.67 million decrease in position value, indicating a cautious stance towards the stock.
- Holding Status: As of September 30, First Wilshire held 206,424 shares of Camtek valued at $21.68 million, representing 5.77% of its total reportable AUM, highlighting the stock's significance in its portfolio.
- Market Performance: Camtek's stock price has risen approximately 30% over the past year, significantly outperforming the S&P 500's 15% increase, showcasing its strong position in the semiconductor equipment sector.
- Financial Health: Camtek reported record Q3 revenue of $126 million, up 12% year-over-year, with non-GAAP operating margins near 30%, indicating robust business momentum driven by AI-related advanced packaging demand.
Trade with 70% Backtested Accuracy
Analyst Views on CAMT
About CAMT
About the author
Camtek to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: Camtek Ltd. will announce its Q4 and full year 2025 financial results on February 18, 2026, reflecting the company's ongoing development and market performance in the semiconductor industry.
- Video Conference Details: Following the earnings release, CEO Rafi Amit, CFO Moshe Eisenberg, and COO Ramy Langer will host a Zoom video conference at 9:00 am ET to discuss the financial results and answer investor questions, enhancing transparency and communication.
- Registration Process: Investors must register in advance to participate in the Zoom call, and upon registration, they will receive a link to the conference, ensuring timely access to the company's latest updates and improving investor relations management.
- Replay Availability: For those unable to attend live, a replay link will be available within hours after the call, ensuring widespread dissemination and accessibility of information, further strengthening the connection between the company and its investors.
Nova Named IBD Stock Of The Day Amid Strong AI-Driven Demand
- AI-Driven Demand Surge: Nova, as a supplier of semiconductor manufacturing equipment, is experiencing strong business growth driven by the AI megatrend, highlighting the company's significant position in a rapidly evolving market.
- Increased Market Recognition: The widespread application of AI technologies has led to a notable increase in demand for Nova's products, further solidifying its leadership in the semiconductor industry.
- Rising Investor Interest: Being named IBD Stock Of The Day reflects heightened investor recognition of Nova's future growth potential, which could drive stock price appreciation.
- Strategic Market Positioning: The company's robust performance in AI-related sectors indicates a strategic alignment with market trends, likely attracting more investor attention moving forward.
First Wilshire Reduces Camtek Stake by $2.67 Million in Q3
- Stake Reduction: First Wilshire Securities Management sold 81,598 shares of Camtek in Q3, resulting in a $2.67 million decrease in stake value, indicating a cautious outlook on the company's future performance.
- Ownership Shift: Following the transaction, First Wilshire's stake in Camtek decreased to 206,424 shares, valued at $21.68 million, which now constitutes 5.77% of its total reportable AUM, reflecting a strategic adjustment in its investment portfolio.
- Market Performance: Camtek shares are currently priced at $109.14, having risen approximately 30% over the past year, significantly outperforming the S&P 500's 15% increase during the same period, showcasing its strong position in the semiconductor equipment sector.
- Financial Health: Camtek reported record third-quarter revenue of $126 million, up 12% year-over-year, with full-year revenue expected to reach around $495 million, indicating sustained growth driven by AI-related advanced packaging demand.
First Wilshire Reduces Camtek Stake by 81,598 Shares, Valuation Drops by $2.67 Million
- Reduction Action: First Wilshire Securities Management sold 81,598 shares of Camtek in Q3, resulting in a $2.67 million decrease in position value, indicating a cautious stance towards the stock.
- Holding Status: As of September 30, First Wilshire held 206,424 shares of Camtek valued at $21.68 million, representing 5.77% of its total reportable AUM, highlighting the stock's significance in its portfolio.
- Market Performance: Camtek's stock price has risen approximately 30% over the past year, significantly outperforming the S&P 500's 15% increase, showcasing its strong position in the semiconductor equipment sector.
- Financial Health: Camtek reported record Q3 revenue of $126 million, up 12% year-over-year, with non-GAAP operating margins near 30%, indicating robust business momentum driven by AI-related advanced packaging demand.
Camtek (CAMT) Shares Decline Even as Market Rises: Key Points to Consider
Stock Performance: Camtek (CAMT) closed at $101.71, down 1.36%, underperforming the S&P 500's gain of 0.79%, but has increased 3.07% over the past month, outperforming the Computer and Technology sector.
Upcoming Financial Results: Analysts expect Camtek to report an EPS of $0.83 and revenue of $127.21 million, reflecting year-over-year increases of 7.79% and 8.46%, respectively.
Analyst Estimates and Zacks Rank: Recent upward revisions in analyst estimates indicate positive sentiment towards Camtek, which currently holds a Zacks Rank of #3 (Hold), with a history of outperforming the market.
Valuation Metrics: Camtek's Forward P/E ratio is 32.15, lower than the industry average of 42.39, and its PEG ratio stands at 2.06, suggesting it may be trading at a discount compared to its peers in the Electronics - Measuring Instruments industry.
Evercore ISI Group Reaffirms Outperform Rating for Camtek (CAMT)
Analyst Recommendation: Evercore ISI Group has maintained an "Outperform" rating for Camtek (NasdaqGM:CAMT) with a projected one-year price target of $119.85/share, indicating a potential upside of 15.25% from its current price of $103.99/share.
Revenue and Earnings Projections: Camtek's projected annual revenue is $399 million, reflecting a decrease of 17.83%, while the expected non-GAAP EPS is 1.60.
Institutional Ownership Trends: There are 292 funds reporting positions in Camtek, with a slight decrease in ownership by 1.68% over the last quarter, although the average portfolio weight dedicated to CAMT has increased by 19.76%.
Shareholder Activity: Notable shareholders like Wasatch Advisors and Clal Insurance have increased their holdings in Camtek significantly, while others like Migdal Insurance have seen a slight decrease in shares owned.
Camtek to Release Q4 and Full Year 2025 Financial Results
- Earnings Release Schedule: Camtek Ltd. will announce its Q4 and full year 2025 financial results on February 18, 2026, reflecting the company's ongoing development and market performance in the semiconductor industry.
- Video Conference Details: Following the earnings release, CEO Rafi Amit, CFO Moshe Eisenberg, and COO Ramy Langer will host a Zoom video conference at 9:00 am ET to discuss the financial results and answer investor questions, enhancing transparency and communication.
- Registration Process: Investors must register in advance to participate in the Zoom call, and upon registration, they will receive a link to the conference, ensuring timely access to the company's latest updates and improving investor relations management.
- Replay Availability: For those unable to attend live, a replay link will be available within hours after the call, ensuring widespread dissemination and accessibility of information, further strengthening the connection between the company and its investors.
Nova Named IBD Stock Of The Day Amid Strong AI-Driven Demand
- AI-Driven Demand Surge: Nova, as a supplier of semiconductor manufacturing equipment, is experiencing strong business growth driven by the AI megatrend, highlighting the company's significant position in a rapidly evolving market.
- Increased Market Recognition: The widespread application of AI technologies has led to a notable increase in demand for Nova's products, further solidifying its leadership in the semiconductor industry.
- Rising Investor Interest: Being named IBD Stock Of The Day reflects heightened investor recognition of Nova's future growth potential, which could drive stock price appreciation.
- Strategic Market Positioning: The company's robust performance in AI-related sectors indicates a strategic alignment with market trends, likely attracting more investor attention moving forward.
First Wilshire Reduces Camtek Stake by $2.67 Million in Q3
- Stake Reduction: First Wilshire Securities Management sold 81,598 shares of Camtek in Q3, resulting in a $2.67 million decrease in stake value, indicating a cautious outlook on the company's future performance.
- Ownership Shift: Following the transaction, First Wilshire's stake in Camtek decreased to 206,424 shares, valued at $21.68 million, which now constitutes 5.77% of its total reportable AUM, reflecting a strategic adjustment in its investment portfolio.
- Market Performance: Camtek shares are currently priced at $109.14, having risen approximately 30% over the past year, significantly outperforming the S&P 500's 15% increase during the same period, showcasing its strong position in the semiconductor equipment sector.
- Financial Health: Camtek reported record third-quarter revenue of $126 million, up 12% year-over-year, with full-year revenue expected to reach around $495 million, indicating sustained growth driven by AI-related advanced packaging demand.
First Wilshire Reduces Camtek Stake by 81,598 Shares, Valuation Drops by $2.67 Million
- Reduction Action: First Wilshire Securities Management sold 81,598 shares of Camtek in Q3, resulting in a $2.67 million decrease in position value, indicating a cautious stance towards the stock.
- Holding Status: As of September 30, First Wilshire held 206,424 shares of Camtek valued at $21.68 million, representing 5.77% of its total reportable AUM, highlighting the stock's significance in its portfolio.
- Market Performance: Camtek's stock price has risen approximately 30% over the past year, significantly outperforming the S&P 500's 15% increase, showcasing its strong position in the semiconductor equipment sector.
- Financial Health: Camtek reported record Q3 revenue of $126 million, up 12% year-over-year, with non-GAAP operating margins near 30%, indicating robust business momentum driven by AI-related advanced packaging demand.
Camtek (CAMT) Shares Decline Even as Market Rises: Key Points to Consider
Stock Performance: Camtek (CAMT) closed at $101.71, down 1.36%, underperforming the S&P 500's gain of 0.79%, but has increased 3.07% over the past month, outperforming the Computer and Technology sector.
Upcoming Financial Results: Analysts expect Camtek to report an EPS of $0.83 and revenue of $127.21 million, reflecting year-over-year increases of 7.79% and 8.46%, respectively.
Analyst Estimates and Zacks Rank: Recent upward revisions in analyst estimates indicate positive sentiment towards Camtek, which currently holds a Zacks Rank of #3 (Hold), with a history of outperforming the market.
Valuation Metrics: Camtek's Forward P/E ratio is 32.15, lower than the industry average of 42.39, and its PEG ratio stands at 2.06, suggesting it may be trading at a discount compared to its peers in the Electronics - Measuring Instruments industry.
Evercore ISI Group Reaffirms Outperform Rating for Camtek (CAMT)
Analyst Recommendation: Evercore ISI Group has maintained an "Outperform" rating for Camtek (NasdaqGM:CAMT) with a projected one-year price target of $119.85/share, indicating a potential upside of 15.25% from its current price of $103.99/share.
Revenue and Earnings Projections: Camtek's projected annual revenue is $399 million, reflecting a decrease of 17.83%, while the expected non-GAAP EPS is 1.60.
Institutional Ownership Trends: There are 292 funds reporting positions in Camtek, with a slight decrease in ownership by 1.68% over the last quarter, although the average portfolio weight dedicated to CAMT has increased by 19.76%.
Shareholder Activity: Notable shareholders like Wasatch Advisors and Clal Insurance have increased their holdings in Camtek significantly, while others like Migdal Insurance have seen a slight decrease in shares owned.
